# Aurinia (AUPH) — Overview

AUPH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/auph

## Price

Last close $16.73 on Oct 15, 2026. 52-week range $11.23 – $18.62.

## Company profile

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $311.5M |
| Revenue (quarter) | $83.2M |
| Revenue growth (year over year) | 18.87% |
| Gross profit (trailing twelve months) | $281.5M |
| Gross margin | 90.36% |
| Net income (trailing twelve months) | $314.1M |
| Net income (quarter) | $37.4M |
| Net income growth (year over year) | 73.91% |
| Net margin | 100.84% |
| Return on equity | 66.12% |
| EPS (trailing twelve months) | $2.36 |
| Book value per share | $4.63 |
| P/E (trailing twelve months) | 7.1 |
| Price to book | 3.6 |
| Debt to assets | 22.39% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Aurinia (AUPH) profitable?

Yes. Aurinia earned $314.1M in net income over the trailing twelve months, a net margin of 100.84%.

### How much revenue does Aurinia (AUPH) make?

Aurinia generated $311.5M in revenue over the trailing twelve months, up 18.87% year over year.

### What is AUPH's P/E ratio?

Aurinia trades at 7.1 times trailing twelve-month earnings, on an EPS of $2.36.

### How do I buy stock in Aurinia (AUPH)?

AUPH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).